SRX is a failure where as OncoSil has already proven complete response in some patients. Sell off is absurd imo.
Response of HHC Target Tumour after Single Fixed Dose of OncoSilTM
+WHO definitions of tumour response * Denotes investigator’s classification. A change of -100% indicated total disappearance of target lesions
Patient Number % Change in target Tumour Volume Response+ 001 -44% Stable Disease 002 -80% Partial Response 003 -16% Stable Disease 004 -43% Partial Response 005 -100% Complete Response 006 -100% Complete Response 007 -100% Complete Response 008 -35% Stable Disease
SRX is a failure where as OncoSil has already proven complete...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $146.9K | 18.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 20491639 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 7540000 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |